NCT07535112 2026-04-16
A Study to Learn More About How Safe BAY 3771249 is and How Well it Works in People With Advanced or Metastatic Colorectal Cancer That Has a KRAS G12D Mutation
Bayer
Phase 1 Not yet recruiting
Bayer
Mirati Therapeutics Inc.
Novartis
Multitude Therapeutics Inc.